The Multibillion-Dollar Opportunity That Sent Argenx Flying 28% Into A Breakout
Investor's Business DailyAn Argenx drug beat expectations in a study of patients with a progressive nerve disorder and ARGX stock catapulted to a record high.
The post The Multibillion-Dollar Opportunity That Sent Argenx Flying 28% Into A Breakout appeared first on Investor's Business Daily.